Potassium
A group of potassium channels with a predicted membrane topology of two TMDs (M1–M2) and a pore (P) domain comprises inward rectifier channels (Kir) and ATP-sensitive (KATP) channels. Currently, seven subfamilies (Kir1–7) have been identified, the majority of which form K+ channels with varying degrees of inward rectification when expressed in heterologous expression systems. They can be classified into four functional groups: classical Kir channels (Kir2.x) are constitutively active, G protein-gated Kir channels (KG or Kir3.x) are regulated by G protein-coupled receptors, ATP-sensitive K+ channels (Kir6.x) are tightly linked to cellular metabolism, and K+ transport channels (Kir1.x, Kir4.x, Kir5.x, and Kir7.x) [1].
[1] H. Hibino et al. Inwardly rectifying potassium channels: their structure, function, and physiological roles. Physiol Rev. 2010 Jan;90(1):291-366.
Axon ID | Name | Description | From price | |
---|---|---|---|---|
3799 | VU6036721 hydrochloride | Inactive enantiomer of VU6036720 hydrochloride | €130.00 | |
3675 | VU6036720 hydrochloride | First potent and selective inhibitor of heteromeric Kir4.1/5.1 inward rectifier potassium channels | €130.00 | |
3593 | VU0468554 | Selective cardiac GIRK inhibitor | €110.00 | |
3365 | Repaglinide | K+ channel blocker (SUR1/Kir6.2 selective) | €90.00 | |
1274 | PNU 37883 hydrochloride | K+ channel blocker (ATP sensitive, vascular) | €95.00 | |
1647 | NN 414 | K+ channel opener (SUR1/Kir6.2 selective) | €110.00 | |
3641 | Nateglinide | KATP channel blocker; inhibits SUR1 | €60.00 | |
2436 | ML 297 | First potent and selective activator of the GIRK potassium channel | €95.00 | |
3490 | Minoxidil | K+ channel opener (ATP sensitive, vascular) | €50.00 | |
4046 | Levosimendan | Calcium sensitiser | €60.00 | |
1757 | HMR 1098 | K+ channel blocker (SUR1/Kir6.2 selective) | €95.00 | |
3503 | Glipizide | KATP channel blocker; inhibits SUR1 | €50.00 | |
2064 | Glibenclamide potassium salt | KATP channel blocker; inhibits SUR1 | €50.00 |